Washington, DC 20006-5349
HELPLINE
Today, Congress voted and passed its budget bill, which included a nearly indefinite renewal of the Zadroga Act, which provides heathcare for first responders and…
This week, we announced the release of a search tool which will enable users on the Meso Foundation’s website to easily search through nearly 100…
The Meso Foundation is pleased to announce that Tobias Peikert, MD, of Mayo Clinic, has taken on the role of its Science Advisory Board’s chair. The…
On October 14, the SELLAS Life Sciences Group, a biotech company leading a Phase 2 study of the WT1 vaccine, released the study’s promising data. The…
Last week, at the World Conference on Lung Cancer, Dr. Raffit Hassan presented promising data on a novel agent, anetumab ravtansine, also known as BAY…
The Meso Foundation congratulates Dr. Harvey Pass for receiving the Merit Award from the International Association for the Study of Lung Cancer (IASLC). Dr. Pass…
We have big news and need your help! Today, the ‘Mary Jo Lawyer-Spano Mesothelioma Patient Registry Act of 2015’ was introduced in Congress by Congressional…
In his most recent State of the Union address, President Obama announced a bold new research effort to revolutionize how we improve health and treat…
A Phase 3 French study, which will be presented at the American Society of Clinical Oncology (ASCO)’s annual meeting at the end of May, demonstrated…
by Melinda Kotzian, Chief Executive Officer, Mesothelioma Applied Research Foundation Over the last 24 hours, news broke that some cancer charities raised funds and did…
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
